Co-Diagnostics, Inc. is trading 10.5% down today at $5.57 as traders react to an S-3 resale registration enabling the sale of up to 4.94 million shares and related warrants.
- The registration has fueled significant dilution concerns and heightened volatility, continuing a trend of sharp price swings observed since late May.
- Broader market weakness and ongoing profit-taking are adding to the selling pressure as investors adjust to the expanded tradable float.